Progyny, Inc.
Close on Oct 19, 2026
- Market cap
- $2.29B
- P/E (TTM)
- 30.3
- Dividend yield
- –
Earnings
Next report expected Nov 5, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 6, 2026 | After market close | $350.50M | – | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 7, 2026 | After market close | $328.50M | $0.29 | $0.50 |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 26, 2026 | After market close | $318.40M | $0.14 | $0.48 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 6, 2025 | After market close | $313.35M | $0.15 | $0.45 |
| Q2 FY2025 Ended Jun 30, 2025 | Jul 8, 2025 | Before market open | – | – | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 8, 2025 | After market close | $324.00M | $0.17 | $0.48 |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 27, 2025 | After market close | $298.40M | $0.12 | $0.42 |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 12, 2024 | After market close | $286.60M | $0.11 | $0.40 |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 6, 2024 | After market close | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 9, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 27, 2024 | After market close | – | – | – |
Company guidance
Outlook given with results on Aug 6, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDAnon-GAAP | Full Year 2026 Outlook | $233.00M to $240.00M | Narrowed |
| Adjusted EBITDAnon-GAAP | Third Quarter of 2026 Outlook | $56.00M to $59.00M | New |
| Adjusted earnings per diluted sharenon-GAAP | Full Year 2026 Outlook | $2.04 to $2.10 | Raised |
| Adjusted earnings per diluted sharenon-GAAP | Third Quarter of 2026 Outlook | $0.50 to $0.52 | New |
| per diluted shareGAAP | Full Year 2026 Outlook | $1.26 to $1.32 | Narrowed |
| per diluted shareGAAP | Third Quarter of 2026 Outlook | $0.30 to $0.33 | New |
| Revenue | Full Year 2026 Outlook | $1.36B to $1.39B | Lowered |
| Revenue | Third Quarter of 2026 Outlook | $335.00M to $345.00M | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Progyny filed with the SEC
Progyny, Inc. Announces Second Quarter 2026 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Progyny, Inc. Announces First Quarter 2026 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
EX-99.1 to Form 8-K
Other events · EX-99.1 to Form 8-K
Progyny, Inc. Announces Fourth Quarter 2025 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference
Results of operations · EX-99.1 to Form 8-K
Progyny, Inc. Announces Third Quarter 2025 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Progyny, Inc. Announces Second Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report
Material agreement · Results of operations · New financial obligation · EX-99.1 to Form 8-K
Progyny, Inc. Announces First Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
Progyny, Inc. Announces Fourth Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K/A
Progyny, Inc. Announces Fourth Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference
Results of operations · EX-99.1 to Form 8-K
Progyny, Inc. Announces Third Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
Progyny, Inc. Announces Second Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
Progyny, Inc. Announces First Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
Progyny, Inc. Announces Fourth Quarter 2023 Results
Results of operations · EX-99.1 to Form 8-K
Progyny, Inc. Announces Third Quarter 2023 Results
Results of operations · EX-99.1 to Form 8-K
Progyny, Inc. Announces Second Quarter 2023 Results
Results of operations · EX-99.1 to Form 8-K
Progyny, Inc. Announces First Quarter 2023 Results
Results of operations · EX-99.1 to Form 8-K
Progyny, Inc. Announces Fourth Quarter 2022 Results
Results of operations · EX-99.1 to Form 8-K
Progyny to Discuss its Strong 2022 Financial Performance at Upcoming Investor Conference
Results of operations · EX-99.1 to Form 8-K
Progyny Raises 2022 Financial Guidance
Regulation FD disclosure · EX-99.1 to Form 8-K
Progyny, Inc. Announces Third Quarter 2022 Results
Results of operations · EX-99.1 to Form 8-K
Progyny, Inc. Announces Second Quarter 2022 Results
Results of operations · EX-99.1 to Form 8-K
Progyny, Inc. Announces First Quarter 2022 Results
Results of operations · EX-99.1 to Form 8-K
Progyny, Inc. Announces Fourth Quarter and Full Year 2021 Results
Results of operations · EX-99.1 to Form 8-K
Progyny, Inc. Announces Third Quarter 2021 Results
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K